Revision as of 19:02, 7 April 2015 by Aparna Vuppala (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
This image is provided by the National Library of Medicine.

WikiDoc Resources for Clofedanol


Most recent articles on Clofedanol

Most cited articles on Clofedanol

Review articles on Clofedanol

Articles on Clofedanol in N Eng J Med, Lancet, BMJ


Powerpoint slides on Clofedanol

Images of Clofedanol

Photos of Clofedanol

Podcasts & MP3s on Clofedanol

Videos on Clofedanol

Evidence Based Medicine

Cochrane Collaboration on Clofedanol

Bandolier on Clofedanol

TRIP on Clofedanol

Clinical Trials

Ongoing Trials on Clofedanol at Clinical

Trial results on Clofedanol

Clinical Trials on Clofedanol at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Clofedanol

NICE Guidance on Clofedanol


FDA on Clofedanol

CDC on Clofedanol


Books on Clofedanol


Clofedanol in the news

Be alerted to news on Clofedanol

News trends on Clofedanol


Blogs on Clofedanol


Definitions of Clofedanol

Patient Resources / Community

Patient resources on Clofedanol

Discussion groups on Clofedanol

Patient Handouts on Clofedanol

Directions to Hospitals Treating Clofedanol

Risk calculators and risk factors for Clofedanol

Healthcare Provider Resources

Symptoms of Clofedanol

Causes & Risk Factors for Clofedanol

Diagnostic studies for Clofedanol

Treatment of Clofedanol

Continuing Medical Education (CME)

CME Programs on Clofedanol


Clofedanol en Espanol

Clofedanol en Francais


Clofedanol in the Marketplace

Patents on Clofedanol

Experimental / Informatics

List of terms related to Clofedanol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Clofedanol (INN) or chlophedianol (BAN) is a centrally acting cough suppressant used in the treatment of dry cough. Clofedanol has local anesthetic and antihistamine properties, and may have anticholinergic effects at high doses.[1] It is marketed in Canada under the trade name Ulone, but is not available currently in the United States. In August 2009, Centrix Pharmaceutical announced the launch of a cough syrup containing a mixture of clophedianol and pseudoephedrine, marketed under the brand name Clofera. It has a release to market date in the beginning of the fourth quarter 2009.[2] Chlophedianol was approved for OTC status in 1987 by the FDA OTC monograph process[3] and its safety and efficacy data are limited.


Clofedanol synthesis: R. Lorenz and H. Henecka, Template:US Patent (1962).


  1. "Clofedanol" (in français). BIAM. 1998-07-24. Retrieved 2007-04-15.
  2. "Centrix Pharmaceutical Announces Clofera(TM), a Unique Antitussive and Nasal Decongestant for the Temporary Relief of Cough and Nasal Congestion". Retrieved 2009-09-27.
  3. "Department of Health and Human Services. Food and Drug Administration. 21 CFR Parts 310, 341, and 369. Docket No. 76N-052T. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the0counter human use; final monograph for OTC antitussive drug products. Federal Register 1987;52(155):30042-57" (PDF). 1987-08-12.

Template:Cough and cold preparations